Management of Severe Hyponatremia (Sodium 118)
For a patient with severe hyponatremia (sodium 118), correction should be performed at a rate not exceeding 8 mEq/L in 24 hours, with careful monitoring every 2 hours to prevent osmotic demyelination syndrome. 1
Initial Assessment and Treatment Approach
For Symptomatic Severe Hyponatremia:
- If severe neurological symptoms present (seizures, coma, severe confusion):
For Asymptomatic or Mildly Symptomatic Hyponatremia:
- Treatment based on volume status assessment:
- Hypovolemic: Isotonic (0.9%) saline infusion
- Euvolemic: Fluid restriction (<1 L/day)
- Hypervolemic: Fluid restriction + treatment of underlying condition 1
Monitoring Protocol
- Check serum sodium every 2 hours in severely symptomatic patients 1
- Monitor urine output and specific gravity every 4 hours 1
- Watch for signs of water diuresis (sudden decrease in urine specific gravity ≥0.010), which can lead to overcorrection 1
Risk Factors for Overcorrection
- Severe symptoms (38% vs 6% overcorrection rate compared to moderate symptoms) 1
- High urine output or water diuresis 1
- Hypovolemia that may be misinterpreted as symptomatic hyponatremia 1
Specific Management Considerations
Pharmacologic Options for Resistant Cases:
- Tolvaptan may be considered for euvolemic or hypervolemic hyponatremia, but:
- Must be initiated in a hospital setting
- Requires close monitoring of serum sodium
- Risk of too rapid correction (>12 mEq/L/24 hours) can cause osmotic demyelination 3
- Starting dose: 15 mg once daily, may increase to 30 mg after 24 hours if needed 3
- Avoid fluid restriction during first 24 hours of tolvaptan therapy 3
Prevention of Osmotic Demyelination Syndrome:
- Patients with severe malnutrition, alcoholism, or advanced liver disease may require slower correction rates 1, 3
- If correction is proceeding too rapidly, consider:
- Administering hypotonic fluids
- Using desmopressin to slow correction 1
Volume Status-Based Treatment Algorithm
| Volume Status | First-Line Treatment | Second-Line Treatment |
|---|---|---|
| Hypovolemic | Isotonic saline infusion | Discontinue diuretics if applicable |
| Euvolemic | Fluid restriction (<1 L/day) | Consider vasopressin antagonists under close monitoring |
| Hypervolemic | Fluid restriction + sodium restriction | Treat underlying condition (heart failure, cirrhosis); consider loop diuretics [1] |
Important Caveats
- Avoid fluid restriction in neurosurgical patients at risk of vasospasm 1
- Patients requiring urgent intervention to raise sodium for serious neurological symptoms should not receive tolvaptan 3
- Following discontinuation of any treatment, monitor for rebound hyponatremia 1, 3
- The optimal correction rate is no more than 8 mEq/L in 24 hours, with careful monitoring to avoid overcorrection 1